Liangyou Duoduo was invited to attend a trade promotion and exchange meeting hosted by the China Chamber of Commerce for Foodstuffs, Native Produce & Animal By-Products, bringing together a delegation from Mato Grosso State, Brazil.

This article explores the evolving landscape of artificial intelligence in healthcare, focusing on recent advances in diagnostic accuracy, predictive analytics, and personalized treatment planning. It examines real-world implementations across radiology, pathology, and chronic disease management, highlighting improved patient outcomes and operational efficiencies. The piece also addresses critical challenges—including data privacy concerns, algorithmic bias, regulatory hurdles, and clinician adoption barriers—while emphasizing the necessity of human-AI collaboration and robust ethical frameworks. Case studies from leading academic medical centers illustrate successful integration strategies, underscoring the importance of interdisciplinary teamwork, transparent AI design, and continuous validation. Ultimately, the article advocates for a balanced, evidence-driven approach to scaling AI tools that prioritize safety, equity, and clinical utility without replacing professional judgment.